InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36,38-39,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1 |
FPZLLRFZJZRHSY-HJYUBDRYSA-N |
[H][C@@]12Cc3c(cc(NC(=O)CNC(C)(C)C)c(O)c3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C |
|
antibacterial drug
A drug used to treat or prevent bacterial infections.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via tetracyclines )
|
|
antibacterial drug
A drug used to treat or prevent bacterial infections.
|
|
View more via ChEBI Ontology
(4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
|
(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
|
ChemIDplus
|
2661
|
DrugCentral
|
C12012
|
KEGG COMPOUND
|
D01079
|
KEGG DRUG
|
DB00560
|
DrugBank
|
View more database links |
220620-09-7
|
CAS Registry Number
|
KEGG COMPOUND
|
220620-09-7
|
CAS Registry Number
|
ChemIDplus
|
8379453
|
Reaxys Registry Number
|
Reaxys
|
17194827
|
PubMed citation
|
ChEMBL
|
17210772
|
PubMed citation
|
ChEMBL
|
17220399
|
PubMed citation
|
ChEMBL
|
17307973
|
PubMed citation
|
ChEMBL
|
17353238
|
PubMed citation
|
ChEMBL
|
17353249
|
PubMed citation
|
ChEMBL
|
|